The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses. ...

By Puyaan Singh and Christy Santhosh April 30 (Reuters) - Companies developing cannabis-based medicines say U.S. moves to ...

Following the recent drug rescheduling from the Trump Administration, medicinal marijuana companies are preparing to raise ...

When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set ...

Acting Attorney General Todd Blanche said he is immediately moving medical marijuana from Schedule I to Schedule III, which ...

A key congressional panel has voted to block the federal rescheduling of marijuana—even though the Trump administration ...

How big is the Black-owned cannabis market? The legal cannabis industry generates billions of dollars annually—reaching an ...

DOJ moves medical cannabis to Schedule III; biotech firms eye funding and IPOs amid banking and tax uncertainty.

Is vaping weed healthier than smoking it? We unpack some benefits, the known harms, and a few unsettling questions sitting ...

The iconic High Times Cannabis Cup competition heads to Atlantic City as New Jersey’s legal cannabis market gains momentum ...

State regulators are warning bad actors who are bringing hemp‑derived, often chemically-altered products into the state's ...